Volume 9, Number 1—January 2003

Research

Shiga Toxin–Producing Escherichia coli Infections Associated with Hemolytic Uremic Syndrome, Italy, 1988–2000

Alberto E. Tozzi* , Alfredo Caprioli*, Fabio Minelli*, Alessandra Gianviti†, Laura De Petris†, Alberto Edefonti‡, Giovanni Montini§, Alfonso Ferretti¶, Tommaso De Palo#, Maurizio Gaido**, Gianfranco Rizzoni‡, and the Hemolytic Uremic Syndrome Study Group

Author affiliations: *Istituto Superiore di Sanità, Rome, Italy; †Ospedale Pediatrico Bambino Gesù, Rome, Italy; ‡Pediatric Clinic “De Marchi,” Milan, Italy; §University of Padua, Padua, Italy; ¶Santobono Hospital, Naples, Italy; #Giovanni XXIII Hospital, Bari, Italy; **Regina Margherita Hospital, Turin, Italy.

Main Article

Figure

Figure. Distribution of hemolytic uremic syndrome cases associated with Shiga toxin–producing Escherichia coli O157, 026, O111, and O145, by year.

Main Article

¹Members of the Hemolytic Uremic Syndrome Study Group are: A. Bettinelli, G. Capasso, A. Caringella, R. Coppo, G. Lama, S. Li Volti, S. Maffei, S. Maringhini, N. Miglietti, C. Pecoraro, I. Pela, M. Pennesi, R. Penza, L. Peratoner, F. Perfumo, I. Ratsche, E. Salvaggio, C. Setzu, and G. Zacchello.

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.